Achilles Therapeutics (Achilles Therapeutics) ROE % Adjusted to Book Value : -92.33% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics ROE % Adjusted to Book Value?

Achilles Therapeutics's ROE % for the quarter that ended in Mar. 2024 was -36.01%. Achilles Therapeutics's PB Ratio for the quarter that ended in Mar. 2024 was 0.39. Achilles Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -92.33%.

Achilles Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Achilles Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics ROE % Adjusted to Book Value Chart

Achilles Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-36.46

-154.00

-157.88

Achilles Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial													-174.48	-170.64	-169.88	-193.77	-92.33

Competitive Comparison of Achilles Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Achilles Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achilles Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achilles Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Achilles Therapeutics's ROE % Adjusted to Book Value falls into.

Achilles Therapeutics ROE % Adjusted to Book Value Calculation

Achilles Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-41.05%	/	0.26
	=	-157.88%

Achilles Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-36.01%	/	0.39
	=	-92.33%

Achilles Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Achilles Therapeutics (Achilles Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

698:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.